Company Analysis Canopy Growth Corporation
1. Summary
Disadvantages
- Price (5.6 $) is higher than fair price (5.17 $)
- Dividends (0%) are below the sector average (0.5468%).
- The stock's return over the last year (-42.61%) is lower than the sector average (-19.51%).
- Current debt level 51.37% has increased over 5 years from 0.5862%.
- The company's current efficiency (ROE=-104.43%) is lower than the sector average (ROE=9.61%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Canopy Growth Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -10.1% | -12.7% | -1.3% |
| 90 days | -36.4% | -27.8% | 9.3% |
| 1 year | -42.6% | -19.5% | 31.8% |
CGC vs Sector: Canopy Growth Corporation has significantly underperformed the "Healthcare" sector by -23.1% over the past year.
CGC vs Market: Canopy Growth Corporation has significantly underperformed the market by -74.45% over the past year.
Stable price: CGC is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CGC with weekly volatility of -0.8194% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (5.6 $) is higher than the fair price (5.17 $).
Price is higher than fair: The current price (5.6 $) is 7.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (24.3) is lower than that of the sector as a whole (48.77).
P/E vs Market: The company's P/E (24.3) is lower than that of the market as a whole (48.89).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.26) is lower than that of the sector as a whole (4.82).
P/BV vs Market: The company's P/BV (1.26) is lower than that of the market as a whole (3.36).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.12) is lower than that of the sector as a whole (33.76).
P/S vs Market: The company's P/S indicator (2.12) is lower than that of the market as a whole (10.23).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-3.6) is higher than that of the sector as a whole (-22.15).
EV/Ebitda vs Market: The company's EV/Ebitda (-3.6) is lower than that of the market as a whole (28.27).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -0.3828% over the last 5 years.
Earnings Slowdown: The last year's return (-80.14%) is below the 5-year average return (-0.3828%).
Profitability vs Sector: The return for the last year (-80.14%) is lower than the return for the sector (-9.16%).
5.4. ROE
ROE vs Sector: The company's ROE (-104.43%) is lower than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (-104.43%) is lower than that of the market as a whole (10.79%).
5.5. ROA
ROA vs Sector: The company's ROA (-35.15%) is lower than that of the sector as a whole (0.3443%).
ROA vs Market: The company's ROA (-35.15%) is lower than that of the market as a whole (6.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-7.11%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (-7.11%) is lower than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5468%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (87.4%) are at a comfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 01.09.2023 | SCHMELING JUDY Director |
Sale | 0.71 | 13 279 | 18 703 |
| 01.09.2023 | Lazzarato David Angelo Director |
Sale | 0.71 | 27 664 | 38 963 |
| 30.06.2023 | Hong Judy Eun Joo Chief Financial Officer |
Sale | 0.52 | 565 | 1 087 |
| 30.06.2023 | Klein David Eric Chief Executive Officer |
Sale | 0.52 | 9 763 | 18 775 |
| 27.06.2023 | SCHMELING JUDY Director |
Sale | 0.62 | 1 153 | 1 859 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
